advertisement
11.4 Prostaglandins (19)
Showing records 1 to 19
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins26797 Effects of topical phenylephrine and tafluprost on optic nerve head circulation in monkeys with unilateral experimental glaucoma
Mayama C; Ishii K; Saeki T; Ota T; Tomidokoro A; Araie M
Investigative Ophthalmology and Visual Science 2010; 51: 4117-4124
26310 Twenty-four-hour ocular hypotensive effects of 0.0015% tafluprost and 0.005% latanoprost in healthy subjects
Mochizuki H; Itakura H; Yokoyama T; Takamatsu M; Kiuchi Y
Japanese Journal of Ophthalmology 2010; 54: 286-290
26476 Intraocular pressure lowering effect of 0.0015% tafluprost as compared to placebo in patients with normal tension glaucoma: randomized, double-blind, multicenter, phase III study
Kuwayama Y; Komemushi S; Tafluprost Multi-center Study Group
Nippon Ganka Gakkai Zasshi 2010; 114: 436-443
26348 Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs
Tanna AP; Rademaker AW; Stewart WC; Feldman RM
Archives of Ophthalmology 2010; 128: 825-833
26649 Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: A comparison of 1 and 6 weeks of treatment
Johnson TV; Fan S; Zhan G; Camras CB; Toris CB
Journal of Glaucoma 2010; 19: 356-364
26373 Prostaglandin Efficacy and Safety Study Undertaken by Race (The PRESSURE Study)
Birt CM; Buys YM; Ahmed II; Trope GE
Journal of Glaucoma 2010; 19: 460-467
26363 Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells
Alvarado JA; Iguchi R; Martinez J; Trivedi S; Shifera AS
American Journal of Ophthalmology 2010; 150: 254-264
26659 A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect
Kobayashi H; Kobayashi K
Journal of Glaucoma 2010;
26881 Focused Conference Group: P11 - G proteincoupled 7TM receptors: From molecular to physiological function rapid characterization of bimatoprost pharmacology in human ocular cells by using cellular dielectric specroscopy
Woodward D; Wang J; Piwnica D; Carling R; Cornell C; Martos J; Stamer D
Basic and Clinical Pharmacology and Toxicology 2010; 107: 659
26672 Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension
Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 287-292
26875 A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension
Hommer A
Drugs of Today 2010; 46: 409-416
26810 Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature
Aydin S; Iikligil I; Teken YA; Kir E
Cutaneous and Ocular Toxicology 2010; 29: 209-213
26555 Intraocular pressure lowering efficacy and safety of travoprost 0.004% as a replacement therapy in patients with open angle glaucoma or ocular hypertension
Ge J; Sun X-H; Wang N-L; Zhao J-L; Wu L-L; Chen X-M; Wang Z-X; Li B
Chinese Medical Journal 2010; 123: 1417-1421
26591 A prostaglandin F(2(alpha)) analogue, bimatoprost, used for glaucoma stimulates scalp hair follicle growth in organ culture; Is this a new approach for alopecia therapy? Hormones, hair growth and pattern hair loss
Khidhir KG; Farjo NP; Farjo BK; Woodward DF; Picksley SM; Randall VA
Experimental Dermatology 2010; 19: 571
26547 IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma
Hommer A; Mohammed Ramez O; Burchert M; Kimmich F
Current Medical Research and Opinion 2010; 26: 1905-1913
26581 Hypertrichosis of the upper cheek area associated with travoprost treatment of glaucoma
Ortiz-Perez S; Olver JM
Ophthalmic Plastic and Reconstructive Surgery 2010; 26: 376-377
26724 A 12-week, randomized, double-masked study of fixed combination latanoprost/timolol versus latanoprost or timolol monotherapy
Palmberg P; Kim EE; Kwok KK; Tressler CS
European Journal of Ophthalmology 2010; 20: 708-718
26730 The combination latanoprost-timolol versus twice daily 0.50% timolol administration either associated or not with latanoprost: efficacy and tolerability in the primary open-angle glaucoma
Pacella E; Pacella F; Cavallotti C; Librando A; Feher J; Pecori-Giraldi J
European review for medical and pharmacological sciences 2010; 14: 477-480
26481 Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy
Asada H; Takaoka-Shichijo Y; Nakamura M; Kimura A
Yakugaku Zasshi 2010; 130: 867-871
